LysoPC (14:0/0:0)
This plasma metabolite, 2- (4-Methoxyphenyl) acetic acid, serves as a highly sensitive and specific biomarker for distinguishing non-small cell lung cancer (NSCLC) patients from healthy individuals. It is a valuable small molecule for research in oncology, metabolomics, and the development of diagnostic assays in both in vitro and clinical studies.
Product Specifications
CAS Number
20559-16-4
Product Name Alternative
Phosphorylcholine, Endogenous Metabolite, EndogenousMetabolite, Inhibitor, inhibit, lysophospholipid, LysoPC (14:0/0:0), Antispasmodic
Field of Research
Metabolism Research
Purity
99.85% (May vary between batches)
Solubility
DMSO:< 0.5 mg/mL; Ethanol:16.67 mg/mL (35.65 mM)
Smiles
CCCCCCCCCCCCCC (=O) OC[C@@H] (O) COP ([O-]) (=O) OCC[N+] (C) (C) C
Molecular Formula
C22H46NO7P
Molecular Weight
467.58
Storage Conditions
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Translocon-Associated Protein Subunit Gamma (SSR3) Antibody (HRP)
Translocon-Associated Protein Subunit Gamma (SSR3) Antibody (HRP)
Translocon-Associated Protein Subunit Gamma (SSR3) Antibody (HRP)